Buchman A L, Jenden D, Suki W N, Roch M
Division of Gastroenterology, Hepatology and Nutrition, University of Texas Houston Health Science Center, USA.
J Ren Nutr. 2000 Jul;10(3):133-8. doi: 10.1053/jren.2000.7411.
Choline deficiency may develop in malnourished patients, those with cirrhosis, and those who require total parenteral nutrition. Previous data has suggested an important role for the kidneys in the maintenance of choline homeostasis.
This study was undertaken to determine the change in plasma choline during hemodialysis and to determine if it was lost in the dialysate.
Thirteen adult patients (10 men, 3 women) who had required hemodialysis for a mean of 10.8 years were studied. Dialysis was performed 3 times weekly for 4 hours using either a cellulose acetate or polysulfone dialyzer membrane. Venous and arterial blood, and dialysate samples were taken for measurement of plasma free and phospholipid-bound choline concentration before beginning dialysis and after each hour of dialysis. An in vitro system was devised to determine if choline could bind to a significant degree to the dialysis membrane.
Plasma free choline concentration was increased above normal (11.7 +/- 3.7 nmol/mL) at baseline and declined progressively during dialysis. In contrast, plasma phospholipid-bound choline concentration increased progressively during dialysis. The decrease in plasma free choline (-1.8 +/- 0.3 nmol/mL(-1)/h(-1); P = 1.6 x 10(-6)) was almost entirely related to that which was removed during dialysis, although the magnitude of the loss was not correlated with the increase in plasma phospholipid-bound choline concentration (125 +/- 20.5 nmol/mL(-1)/h(-1); P < 1.2 x 10(-6)). Patients lost a mean of 246 pmol of free choline during hemodialysis. Choline did not bind to the dialysis membrane.
Plasma free choline concentration is elevated before dialysis, and choline is lost to a significant degree in the dialysate. Further investigation is necessary to determine whether a transient, dialysis-induced choline deficiency develops, and whether there is a role for choline supplementation in these patients. The choline homeostatic mechanism requires further investigation in renal failure patients.
营养不良患者、肝硬化患者以及需要全胃肠外营养的患者可能会出现胆碱缺乏。既往数据表明,肾脏在维持胆碱稳态方面发挥着重要作用。
本研究旨在确定血液透析期间血浆胆碱的变化,并确定其是否在透析液中丢失。
对13例成年患者(10例男性,3例女性)进行研究,这些患者平均需要血液透析10.8年。使用醋酸纤维素或聚砜透析器膜,每周进行3次透析,每次4小时。在透析开始前以及透析每小时后,采集静脉血、动脉血和透析液样本,用于测定血浆游离胆碱和磷脂结合胆碱浓度。设计了一个体外系统,以确定胆碱是否能在很大程度上与透析膜结合。
基线时血浆游离胆碱浓度高于正常水平(11.7±3.7 nmol/mL),并在透析过程中逐渐下降。相比之下,血浆磷脂结合胆碱浓度在透析过程中逐渐升高。血浆游离胆碱的下降(-1.8±0.3 nmol/mL⁻¹/h⁻¹;P = 1.6×10⁻⁶)几乎完全与透析过程中去除的量有关,尽管丢失的幅度与血浆磷脂结合胆碱浓度的升高(125±20.5 nmol/mL⁻¹/h⁻¹;P < 1.2×10⁻⁶)无关。患者在血液透析期间平均丢失246 pmol游离胆碱。胆碱未与透析膜结合。
透析前血浆游离胆碱浓度升高,且胆碱在透析液中大量丢失。需要进一步研究以确定是否会出现短暂的、透析诱导的胆碱缺乏,以及这些患者补充胆碱是否有作用。胆碱稳态机制在肾衰竭患者中需要进一步研究。